Silverstein Christine Berni 4

What Happened

• Christine Berni Silverstein, a director of Abeona Therapeutics, received a grant of 37,313 restricted common shares on January 26, 2026. The reported acquisition price is $0.00 (code A — award/grant). The filing shows the shares were acquired as an award rather than a cash purchase or sale.

Key Details

• Transaction date: 2026-01-26; Report filed: 2026-01-27 (timely filing)
• Grant size and price: 37,313 restricted shares at $0.00 (award)
• Vesting: All restricted shares will vest on January 26, 2027 (footnote F1)
• Shares owned after transaction: Not specified in the provided excerpt of the Form 4
• Filing timeliness: No late-filing indicator; appears filed within the normal Form 4 window

Context

• This was a compensation award (restricted stock) rather than an open-market purchase or sale. Such awards typically reflect board/compensation decisions and vesting schedules; they do not necessarily indicate immediate buying or selling intent. The shares are subject to vesting and likely cannot be sold until vesting conditions are met.